{"id":"https://openalex.org/W2103064566","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","title":"Are there clinical benefits associated with treatment of mild chemotherapy-induced anemia (CIA)? A systematic review","display_name":"Are there clinical benefits associated with treatment of mild chemotherapy-induced anemia (CIA)? A systematic review","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2103064566","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","mag":"2103064566"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.8194","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101631020","display_name":"Giuseppe Rossi","orcid":"https://orcid.org/0000-0001-8377-2898","observed_orcids":["https://orcid.org/0000-0001-8377-2898"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Rossi","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Glaspy","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073060840","display_name":"Gary H. Lyman","orcid":"https://orcid.org/0000-0002-0823-8086","observed_orcids":["https://orcid.org/0000-0002-0823-8086"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Lyman","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA; UCLA Sch of Medicine, Los Angeles, CA; James P. Wilmot Cancer Ctr, Rochester, NY","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"8194","last_page":"8194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/early-versus-late-intervention","display_name":"early versus late intervention","score":0.5270000100135803},{"id":"https://openalex.org/keywords/hemoglobin-threshold","display_name":"hemoglobin threshold","score":0.7929999828338623},{"id":"https://openalex.org/keywords/mild-anemia","display_name":"mild anemia","score":0.6610000133514404},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.8019999861717224},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.8159999847412109},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.6970000267028809},{"id":"https://openalex.org/keywords/hematocrit-monitoring","display_name":"hematocrit monitoring","score":0.33000001311302185},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6790000200271606},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9520021080970764},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.7151291370391846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6307517886161804},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.616801917552948},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5842322111129761},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5276317000389099},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4889882802963257},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.48618263006210327},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4771827459335327},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4205315113067627},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33912643790245056},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25994545221328735},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.8194","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.8194","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087353174","https://openalex.org/W2580351549","https://openalex.org/W128003550","https://openalex.org/W2588458120","https://openalex.org/W4211109553","https://openalex.org/W2014914411","https://openalex.org/W2167467743","https://openalex.org/W7095871261","https://openalex.org/W2123088163","https://openalex.org/W2567405999"],"abstract_inverted_index":{"8194":[0],"Background:":[1],"American":[2],"Society":[3,7],"of":[4,8,18,38,92,135,148,168,178,193,235,278,288],"Hematology":[5],"[ASH]/American":[6],"Clinical":[9],"Oncology":[10],"[ASCO]":[11],"clinical":[12,57,273],"practice":[13],"guidelines":[14],"for":[15],"the":[16,36,90,146,176,232],"management":[17],"CIA":[19,279],"recommend":[20],"initiating":[21,39,61],"erythropoietic":[22,40,62,94,141,276],"therapy":[23,41,63],"at":[24,285],"hemoglobin":[25],"(Hb)":[26],"\u2264":[27],"10":[28,70,113,183,240],"g/dL.":[29,71,290],"However,":[30],"there":[31,55],"is":[32],"increasing":[33],"debate":[34],"regarding":[35],"benefits":[37,58,274],"in":[42,64,163,219,231],"patients":[43,66,179],"with":[44,60,67,130,139,180,186,189,283],"mild":[45,169],"anemia.":[46],"We":[47],"conducted":[48],"a":[49,229],"systematic":[50],"review":[51],"to":[52,83,105,108],"determine":[53],"if":[54],"are":[56],"associated":[59,129,138],"cancer":[65],"Hb":[68,99,181,238,286],"\u2265":[69],"Methods:":[72],"Medline":[73],"database":[74],"and":[75,79,107,150,161,175,203,222,237,255],"conference":[76],"proceedings":[77],"(ASH":[78],"ASCO)":[80],"were":[81,116,143,159,225],"searched":[82],"identify":[84],"randomized":[85],"controlled":[86],"trials":[87],"that":[88,120,271],"evaluated":[89],"effect":[91],"early":[93,140,221,243],"intervention":[95,110,142,224,244],"on":[96],"transfusion":[97,173],"incidence,":[98],"concentration,":[100],"and/or":[101],"patient-reported":[102],"outcomes":[103],"relative":[104,136,190,233],"control":[106],"late":[109,223],"(Hb":[111],"<":[112,182,201,239,253,264],"g/dL).":[114],"Data":[115],"extracted":[117],"from":[118,217,275],"studies":[119,154,218],"met":[121],"prespecified":[122],"eligibility":[123],"criteria.":[124],"For":[125],"outcome":[126],"measures":[127,134],"not":[128],"significant":[131],"heterogeneity,":[132],"summary":[133],"risk":[137,191,234],"estimated":[144],"using":[145],"method":[147],"Mantel":[149],"Haenszel.":[151],"Results:":[152],"Eleven":[153],"(5":[155],"papers,":[156],"6":[157,198],"abstracts)":[158],"identified":[160],"included":[162],"this":[164],"analysis.":[165],"Erythropoietic":[166],"treatment":[167,277],"anemia":[170],"effectively":[171],"decreased":[172],"incidence":[174],"proportion":[177],"g/dL":[184,241],"compared":[185,226],"no":[187],"treatment,":[188],"reductions":[192],"0.47":[194],"(95%":[195,205,257],"CL:0.38,":[196],"0.57;":[197],"studies,":[199,210,251,262],"P":[200,211,252,263],".001)":[202,254],"0.48":[204],"CL:":[206,247,258],"0.25,":[207],"0.89;":[208],"4":[209],"=":[212],".195),":[213],"respectively.":[214,266],"The":[215],"findings":[216,269],"which":[220],"also":[227],"indicated":[228],"reduction":[230],"transfusions":[236],"following":[242],"(0.55":[245],"[95%":[246],"0.42,":[248],"0.73;":[249],"5":[250],"0.42":[256],"0.32,":[259],"0.56;":[260],"2":[261],".001),":[265],"Conclusions:":[267],"These":[268],"suggest":[270],"optimal":[272],"may":[280],"be":[281],"achieved":[282],"initiation":[284],"levels":[287],"10\u201312":[289],"Author":[291],"Disclosure":[292],"Employment":[293],"or":[294,297],"Leadership":[295],"Consultant":[296],"Advisory":[298],"Role":[299],"Stock":[300],"Ownership":[301],"Honoraria":[302],"Research":[303],"Funding":[304],"Expert":[305],"Testimony":[306],"Other":[307],"Remuneration":[308],"Amgen":[309,310,311,312,313]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}